FUTURE PROOF YOUR CELL and GENE THERAPY
at RESILIENCE
Resilience is a first-of-kind technology-based manufacturing company, building a network of high-tech biomanufacturing platforms and capacity to ensure the medicines of today and tomorrow can be made at the quality, cost, and scale to meet patient needs. Resilience offers solutions for cell and gene therapy services from early clinical through commercial manufacturing, including: PAD, cell banking, viral vectors (AAV, LVV), and others, immunotherapies, HSCs, iPSCs, and regenerative medicines.